Functional involvement of rat organic anion transporter 2 (SLC22A7) in the hepatic uptake of the nonsteroidal anti-inflammatory drug ketoprofen

Rat organic anion transporter 2 (rOat2, Slc22a7) is a sinusoidal multispecific organic anion transporter in the liver. The role of rOat2 in the hepatic uptake of drugs has not been thoroughly investigated yet. rOat2 substrates include nonsteroidal anti-inflammatory drugs, such as ketoprofen, indomethacin, and salicylate. In the present study, the uptake of ketoprofen, indomethacin, and salicylate by freshly isolated rat hepatocytes was characterized. The uptake of ketoprofen, indomethacin, and salicylate by hepatocytes was sodium-independent, and the rank order of their uptake activities was indomethacin > ketoprofen > salicylate. Kinetic analysis based on Akaike's Information Criterion suggested that the uptake of ketoprofen and indomethacin by hepatocytes consists of two saturable components and one nonsaturable one. The K-m and V-max values for the high- and low-affinity components for ketoprofen uptake were 0.84 and 97 mu M and 35 and 1800 pmol/min/mg protein, respectively, whereas those for indomethacin were 1.1 and 140 mu M and 130 and 16,000 pmol/min/mg protein, respectively. The K-m values of the high- affinity component were similar to those for rOat2 (3.3 and 0.37 mu M for ketoprofen and indomethacin, respectively). The uptake of ketoprofen by hepatocytes was significantly inhibited by probenecid and rOat2 inhibitors (indocyanine green, indomethacin, glibenclamide, and salicylate). Other inhibitors of rOatps (taurocholate and pravastatin) and rOat3 (pravastatin and p-aminohippurate) had a slight effect, but digoxin had no effect. These results suggest that rOat2 accounts partly for the hepatic uptake of ketoprofen and, presumably, indomethacin as a high- affinity site and that other transporters, such as rOatps, but not rOatp2, and rOat3, are also involved.